1.
3.
4.
5.
6.
Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
(feeds.content.dowjones.io)
7.
Novartis to Buy Biotech Excellergy for Up to $2 Billion
(feeds.content.dowjones.io)
8.
Briefing Chat: ‘Zombie cells’ resurrected with new genes
(feeds.nature.com)
9.
10.
Government agencies buy commercial data about Americans in bulk
(news.ycombinator.com)
11.
13.
Arinna raises $4M seed round to solve the space power problem
(techcrunch.com)
14.
15.
Redirecting current solves a shadowy problem faced by perovskite solar cells
(feeds.nature.com)
16.
Parasites trigger epithelial cell crosstalk to drive gut–brain signalling
(feeds.nature.com)
17.
19.
‘Zombie cells’ return from the dead — after a genome transplant
(feeds.nature.com)
20.
Daily briefing: We’ve just had the 11 hottest years on record
(feeds.nature.com)
21.
22.
23.
Oregon school cell phone ban: 'Engaged students, joyful teachers'
(news.ycombinator.com)
24.
Oregon School Cell Phone Ban: 'Engaged Students, Joyful Teachers'
(news.ycombinator.com)
25.
26.
Ubisoft ends development at Tom Clancy studio Red Storm
(engadget.com)
27.
All the wrong EVs are getting cancelled
(theverge.com)
28.
Stress can cause eczema to flare-up – now we know why
(feeds.nature.com)
29.
Masked mitochondria slip into cells to treat disease in mice
(feeds.nature.com)
30.
Today's top topics:
apple
google
amazon
meta
openai
anthropic
zdnet
chatgpt
android authority
social media